Company Number: 14778904

Analysis Date: 2025-07-20 17:06 UTC

Financial Health Assessment for SWISSCHEMGAS UK LTD
As of 30 June 2024

---

1. Financial Health Score: C

Explanation:
SWISSCHEMGAS UK LTD shows basic signs of financial viability with positive net current assets and shareholders’ funds. However, the company operates with a very narrow working capital margin and a significant proportion of current liabilities relative to current assets. The absence of employees and reliance on substantial other creditors suggest early-stage operational development with potential liquidity strain. The financial health is cautious but not critical, meriting a mid-level grade.

---

2. Key Vital Signs

Metric	Value (USD)	Interpretation
Current Assets	1,724,478	Healthy cash and debtor levels indicating liquid resources available.
- Cash at bank and in hand	1,652,656	Strong cash position, a vital sign of healthy cash flow and liquidity.
- Trade debtors	71,632	Moderate receivables, manageable but needs monitoring for timely collection.
Current Liabilities	1,670,879	Very high short-term obligations, creating a tight liquidity situation.
- Trade creditors	74,587	Normal trade payables, not alarming.
- Taxation and social security	17,998	Standard current tax and social obligations.
- Other creditors	1,578,294	Large "other creditors" balance, potential sign of significant short-term financing or accrued expenses. Needs detailed review.
Net Current Assets	53,599	Positive but very slim working capital; indicates limited buffer to cover short-term debts.
Shareholders' Funds (Equity)	53,599	Positive equity, indicating the company is not insolvent; however, the margin is thin.
Number of Employees	0	No employees reported, possibly indicating outsourced operations or early startup phase.
Turnover & Profit	Not explicitly disclosed	Profit and loss account figures not provided, limiting insight into profitability.

---

3. Diagnosis: Financial Symptoms and Underlying Health

• Liquidity Condition: The company shows a "healthy cash flow" sign with over $1.65 million in cash. However, the "symptom of distress" is the very high current liabilities of $1.67 million, mainly from 'other creditors'. This creates a narrow net current asset margin of just $53,599, indicating that the company’s short-term obligations almost match its liquid assets. Such a tight margin suggests the company must carefully manage its cash flow to avoid liquidity crises.

• Capital Structure: Shareholders' funds are positive but minimal, reflecting the company's recent incorporation (2023) and early operational stage. Positive equity is a good sign but thin, implying limited financial resilience against unexpected costs or downturns.

• Operational Status: Zero employees suggest the company may be at a nascent stage or relying heavily on contractors, outsourcing, or automated systems. This could minimize fixed overhead costs but may put pressure on operational flexibility and control.

• Revenue Recognition: The company’s turnover arises from vessel chartering, recognized by contract completion stage. Without turnover or profit details, the company’s operational profitability and sustainability cannot be fully assessed.

• Financial Reporting: The company has filed full exemption accounts and is compliant with filing deadlines, showing good administrative health and adherence to statutory obligations.

---

4. Recommendations: Prescriptions for Financial Wellness

• Improve Working Capital Buffer: The company should aim to reduce 'other creditors' or convert some short-term liabilities into longer-term obligations to ease liquidity pressure. Building a healthier net current asset margin will provide a financial cushion against unforeseen expenses.

• Detailed Creditor Analysis: Review the composition of the large "other creditors" balance for potential restructuring or negotiation with suppliers and financiers to optimize cash flow management.

• Profit and Loss Transparency: Consider producing and reviewing detailed profit and loss accounts to gain better insight into operational profitability and cost management.

• Cash Flow Monitoring: Maintain rigorous cash flow forecasting and monitoring, especially given the tight liquidity. Focus on accelerating debtor collections and managing payment terms with creditors.

• Strategic Growth Planning: As a young company with no employees, evaluate whether scaling operations and hiring staff or outsourcing is optimal for sustainable growth.

• Financial Controls and Risk Management: Implement or strengthen internal controls to avoid over-reliance on short-term financing and ensure compliance with tax and regulatory obligations.

---

Medical Analogy Summary

SWISSCHEMGAS UK LTD is akin to a patient recently admitted to the hospital: it has a strong heartbeat (healthy cash reserves) but is showing early symptoms of stress from a heavy treatment load (high current liabilities). While not in critical condition, it needs attentive care—particularly in managing its short-term obligations and operational cash flow—to avoid deterioration.

---